Exane Derivatives’s Spring Valley Acquisition Corp. Class A Ordinary Share SV Stock Holding History

Exane Derivatives’s Portfolio SV Stock Details SV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-50,000	Closed	-$523K	–	1065
2022 Q1	$523K	Hold	50,000	–	–	0.15%	181
2021 Q4	$501K	Buy	+50,000	New	+$491K	0.12%	177

Other funds holding SV

GWS

Glassman Wealth Services Vienna, Virginia $835M AUM 22.94% 1-Year Est. Return

Exane Derivatives's SV Position: Q2 2022 in Review

Exane Derivatives sold out of Spring Valley Acquisition Corp. Class A Ordinary Share (SV) in Q2 2022, closing a stake of 50,000 shares — an estimated $523K sold.

Exane Derivatives first reported a position in SV in Q4 2021 and held it in 2 quarters. The position peaked at $523K in Q1 2022. 2 funds tracked by Wall St. Rank hold SV as of Q2 2022.

Exane Derivatives reported no remaining Spring Valley Acquisition Corp. Class A Ordinary Share position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 50,000 Spring Valley Acquisition Corp. Class A Ordinary Share shares in Q2 2022, an estimated $523K.
Exane Derivatives first reported a position in Spring Valley Acquisition Corp. Class A Ordinary Share in Q4 2021 and held it in 2 quarters.
Exane Derivatives's Spring Valley Acquisition Corp. Class A Ordinary Share position peaked at $523K in Q1 2022.
2 funds tracked by Wall St. Rank held Spring Valley Acquisition Corp. Class A Ordinary Share as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.